Contraceptive devices placed high in the uterine fundus.
Intrauterine contraceptive devices that depend on the release of metallic copper.
Devices that diminish the likelihood of or prevent conception. (From Dorland, 28th ed)
Chemical substances that prevent or reduce the probability of CONCEPTION.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
Contraceptive devices used by females.
The shifting in position or location of an INTRAUTERINE DEVICE from its original placement.
Fixed drug combinations administered orally for contraceptive purposes.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
A hole or break through the wall of the UTERUS, usually made by the placement of an instrument or INTRAUTERINE DEVICES.
Spontaneous loss of INTRAUTERINE DEVICES from the UTERUS.
Intrauterine devices that release contraceptive agents.
Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.
A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
Oral contraceptives which owe their effectiveness to hormonal preparations.
Behavior patterns of those practicing CONTRACEPTION.
Oral contraceptives which owe their effectiveness to synthetic preparations.
Inflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy (PREGNANCY, ECTOPIC)
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
Health care programs or services designed to assist individuals in the planning of family size. Various methods of CONTRACEPTION can be used to control the number and timing of childbirths.
Polymeric materials (usually organic) of large molecular weight which can be shaped by flow. Plastic usually refers to the final product with fillers, plasticizers, pigments, and stabilizers included (versus the resin, the homogeneous polymeric starting material). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Infections with bacteria of the genus ACTINOMYCES.
Excessive uterine bleeding during MENSTRUATION.
Migration of a foreign body from its original location to some other location in the body.
A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.
Removal of an implanted therapeutic or prosthetic device.
Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.
Contraceptive devices used by males.
A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents.
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
Contraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs; progesterone-receptor blockers; ANTIMETABOLITES; ALKALOIDS, and PROSTAGLANDINS.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.
A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
Vaccines or candidate vaccines used to prevent conception.
A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.
Unintended accidental pregnancy, including pregnancy resulting from failed contraceptive measures.
Procedures to block or remove all or part of the genital tract for the purpose of rendering individuals sterile, incapable of reproduction. Surgical sterilization procedures are the most commonly used. There are also sterilization procedures involving chemical or physical means.
Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.
Pregnancy, usually accidental, that is not desired by the parent or parents.
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Means of postcoital intervention to avoid pregnancy, such as the administration of POSTCOITAL CONTRACEPTIVES to prevent FERTILIZATION of an egg or implantation of a fertilized egg (OVUM IMPLANTATION).
Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives.
The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.
Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)
A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive.
Contraceptive methods based on immunological processes and techniques, such as the use of CONTRACEPTIVE VACCINES.
Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..
ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions. It has proved to be an effective contraceptive (CONTRACEPTIVES, ORAL, COMBINED).
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
Methods of creating machines and devices.
Drugs administered orally and sequentially for contraceptive purposes.
Postcoital contraceptives which owe their effectiveness to hormonal preparations.
Procedures that render the female sterile by interrupting the flow in the FALLOPIAN TUBE. These procedures generally are surgical, and may also use chemicals or physical means.
Freedom of equipment from actual or potential hazards.
Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome.
Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL).
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.
Expendable and nonexpendable equipment, supplies, apparatus, and instruments that are used in diagnostic, surgical, therapeutic, scientific, and experimental procedures.
Variations of menstruation which may be indicative of disease.
Pregnancy in human adolescent females under the age of 19.
17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.
Postcoital contraceptives which owe their effectiveness to synthetic preparations.
Education which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction.
Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa.
Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.
(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
The capacity to conceive or to induce conception. It may refer to either the male or female.

Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. (1/72)

CONTEXT: Unintended pregnancy remains a major public health concern in the United States. Information on pregnancy rates among contraceptive users is needed to guide medical professionals' recommendations and individuals' choices of contraceptive methods. METHODS: Data were taken from the 1995 National Survey of Family Growth (NSFG) and the 1994-1995 Abortion Patient Survey (APS). Hazards models were used to estimate method-specific contraceptive failure rates during the first six months and during the first year of contraceptive use for all U.S. women. In addition, rates were corrected to take into account the underreporting of induced abortion in the NSFG. Corrected 12-month failure rates were also estimated for subgroups of women by age, union status, poverty level, race or ethnicity, and religion. RESULTS: When contraceptive methods are ranked by effectiveness over the first 12 months of use (corrected for abortion underreporting), the implant and injectables have the lowest failure rates (2-3%), followed by the pill (8%), the diaphragm and the cervical cap (12%), the male condom (14%), periodic abstinence (21%), withdrawal (24%) and spermicides (26%). In general, failure rates are highest among cohabiting and other unmarried women, among those with an annual family income below 200% of the federal poverty level, among black and Hispanic women, among adolescents and among women in their 20s. For example, adolescent women who are not married but are cohabiting experience a failure rate of about 31% in the first year of contraceptive use, while the 12-month failure rate among married women aged 30 and older is only 7%. Black women have a contraceptive failure rate of about 19%, and this rate does not vary by family income; in contrast, overall 12-month rates are lower among Hispanic women (15%) and white women (10%), but vary by income, with poorer women having substantially greater failure rates than more affluent women. CONCLUSIONS: Levels of contraceptive failure vary widely by method, as well as by personal and background characteristics. Income's strong influence on contraceptive failure suggests that access barriers and the general disadvantage associated with poverty seriously impede effective contraceptive practice in the United States.  (+info)

Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. (2/72)

CONTEXT: Half of all pregnancies in the United States are unintended. Of these, half occur to women who were practicing contraception in the month they conceived, and others occur when couples stop use because they find their method difficult or inconvenient to use. METHODS: Data from the 1995 National Survey of Family Growth were used to compute life-table probabilities of contraceptive failure for reversible methods of contraception, discontinuation of use for a method-related reason and resumption of contraceptive use. RESULTS: Within one year of starting to use a reversible method of contraception, 9% of women experience a contraceptive failure--7% of those using the pill, 9% of those relying on the male condom and 19% of those practicing withdrawal. During a lifetime of use of reversible methods, the typical woman will experience 1.8 contraceptive failures. Overall, 31% of women discontinue use of a reversible contraceptive for a method-related reason within six months of starting use, and 44% do so within 12 months; however, 68% resume use of a method within one month and 76% do so within three months. Multivariate analyses show that the risk of contraceptive failure is elevated among low-income women and Hispanic women. Low-income women are also less likely than other women to resume contraceptive use after discontinuation. CONCLUSIONS: The risks of pregnancy during typical use of reversible methods of contraception are considerably higher than risks of failure during clinical trials, reflecting imperfect use of these methods rather than lack of inherent efficacy. High rates of method-related discontinuation probably reflect dissatisfaction with available methods.  (+info)

Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule. (3/72)

The Food and Drug Administration (FDA) is issuing a final rule to require the filing of a premarket approval application (PMA) or a notice of completion of product development protocol (PDP) for glans sheath medical devices. The agency has previously published its findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet the statute's approval requirements and the benefits to the public from the use of the devices.  (+info)

Contraceptive security, information flow, and local adaptations: family planning Morocco. (4/72)

BACKGROUND: Many developing countries increasingly recognize and acknowledge family planning as a critical part of socio-economic development. However, with few health dollars to go around, countries tend to provide essential drugs for curative care, rather than for family planning products. Donors have historically provided free contraceptives for family planning services. Whether products are donated or purchased by the country, a successful family planning program depends on an uninterrupted supply of products, beginning with the manufacturer and ending with the customer. Any break in the supply chain may cause a family planning program to fail. A well-functioning logistics system can manage the supply chain and ensure that the customers have the products they need, when they need them. METHODOLOGY: Morocco was selected for the case study. The researchers had ready access to key informants and information about the Logistics Management Information System. Because the study had time and resource constraints, research included desktop reviews and interview, rather than data collection in the field. RESULTS: The case study showed that even in a challenging environment an LMIS can be successfully deployed and fully supported by the users. It is critical to customize the system to a country-specific situation to ensure buy-in for the implementation. CONCLUSIONS: Significant external support funding and technical expertise are critical components to ensure the initial success of the system. Nonetheless, evidence from the case study shows that, after a system has been implemented, the benefits may not ensure its institutionalization. Other support, including local funding and technical expertise, is required.  (+info)


Sexual sterilization is legal when it is an integral part of a procedure for the preservation of the life or health of a patient. Done for other reasons it may not be illegal, but this has not been tested in Canadian courts. It is, broadly speaking, a surgical procedure; it is commonly, but not always, successful; complications, while rare, do occur; the results tend to be irreversible. The same end, the prevention of pregnancy, may be attained by other methods which are safer, less liable to complications, less permanent and so should be used unless contraindicated. Patients' statements that they do not like contraceptives should not be accepted as a reason for sterilization. Sexual sterilization should be reserved for those occasions when it is necessary for the preservation of the health or life of the individual who is to be sterilized.  (+info)

Gender issues in contraceptive use among educated women in Edo state, Nigeria. (6/72)

BACKGROUND: While traditional contraception is widely used, in southern Nigerian modern contraception is a relatively recent phenomenon. Modern contraception is more wide spread among the educated and sexually active youth in Nigeria. Few studies have been done on contraception among educated women in Nigeria. OBJECTIVES: This study was carried out in December 2000 to determine factors that influence the choice of contraceptives among female undergraduates at the University of Benin and Edo State University Ekpoma. METHODS: Data was collected from a sample of 800 female undergraduates matched ethnic group, socio economic status, religion and rural urban residence. Subjects were selected by proportional representation and the instrument used was closed ended questionnaire. RESULTS: The responses obtained were analysed using Spearman Rank Correlation co-efficient and regression analysis. Findings revealed the highest correlation for availability (r =.96) vis a vis the use of various types of artificial contraceptive and cost (r =.96), next was safety (r =.95) and effectiveness (r =.95). Others were peer group influence (r =.80) and convenience (r =.77). CONCLUSION: An important step in improving women's reproductive health is the involvement of men. Health programmes should conduct campaigns to educate men about reproductive health and the role they can assume in family planning.  (+info)

Contraceptive use and consistency in U.S. teenagers' most recent sexual relationships. (7/72)

CONTEXT: Most U.S. teenage pregnancies are unintended, partly because of inconsistent or no use of contraceptives. Understanding the factors associated with contraceptive use in teenagers' most recent relationships can help identify strategies to prevent unintended pregnancy. METHODS: Data on 1,468 participants in Waves 1 and 2 of the National Longitudinal Study of Adolescent Health who had had two or more sexual relationships were analyzed to assess factors associated with contraceptive use patterns in teenagers' most recent sexual relationship. Odds ratios were generated through logistic regression. RESULTS: Many relationship and partner characteristics were significant for females but nonsignificant for males. For example, females' odds of ever, rather than never, having used contraception in their most recent relationship increased with the duration of the relationship (odds ratio, 1.1); their odds were reduced if they had not known their partner before dating him (0.2). The odds of consistent use (vs. inconsistent or no use) were higher for females in a "liked" relationship than for those in a romantic relationship (2.6), and for females using a hormonal method instead of condoms (4.5). Females' odds of consistent use decreased if the relationship involved physical violence (0.5). Among teenagers in romantic or "liked" relationships, the odds of ever-use and of consistent use were elevated among females who had discussed contraception with the partner before their first sex together (2.9 and 2.1, respectively), and the odds increased among males as the number of presexual couple-like activities increased (1.2 for each). CONCLUSIONS: Teenagers must use contraception consistently over time and across relationships despite pressure not to. Therefore, they must learn to negotiate sexual and contraceptive decisions in each relationship.  (+info)

Women with septic abortion: who, how and why? A prospective study from tertiary care hospital in India. (8/72)

A prospective descriptive interview based hospital study was carried on 47 women admitted with septic abortion to evaluate their psychosocial, demographic and clinical profile These women were predominantly parous (75%), hindus (60%), between 20-30 years of age (60%) and mostly married (91.4%) house wives (63.8%). More than 90% already had one or more male child. The contraceptive use was dismally low (23.4%). Their knowledge about legalisation, place and persons authorized to conduct abortions was very less, however large majority (87%) underwent abortions within 3 months of pregnancy. Large family, poverty and spacing were the main reasons cited for abortions. Abdominal pain, fever, genital bleeding, diarhoea and abdominal distension were presenting clinical features in order of frequency. Advanced sepsis and associated medical and surgical complications were present in more than half the patients and 6% succumbed to these problems. The current experience was an eye opener for most of them and changed their future attitude. Hence education, economic prosperity, easy access to reproductive health facilities and institutional management of sepsis is the key to make abortions safe.  (+info)

The symptoms of intrauterine device migration can vary depending on the location and size of the migrated IUD. Some common symptoms include:

* Abnormal bleeding or spotting
* Painful menstrual cramps
* Difficulty inserting or removing the IUD during routine check-ups
* Fever, chills, or other signs of infection

If intrauterine device migration is suspected, a healthcare provider will typically perform a physical examination and order imaging tests, such as an ultrasound or X-ray, to confirm the location and size of the migrated IUD. Treatment options for intrauterine device migration depend on the severity of the complication and can include:

* Removal of the migrated IUD
* Insertion of a new IUD in a different location
* Antibiotics to treat any underlying infections
* Surgical intervention to repair any damage caused by the migrated IUD.

It is important for women who use intrauterine devices (IUDs) as a form of birth control to be aware of the risk of migration and seek medical attention if they experience any symptoms that may indicate a problem with their IUD. Regular check-ups with a healthcare provider can help detect any issues early on and prevent complications associated with intrauterine device migration.

There are different types of uterine perforation, including:

1. Cervical perforation: A tear in the cervix, which is the lower part of the uterus that opens into the vagina.
2. Uterine wall perforation: A tear or hole in the muscular wall of the uterus, which can be caused by instruments used during surgery or delivery.
3. Endometrial perforation: A tear in the lining of the uterus (endometrium), which is more common during invasive procedures such as hysteroscopy or endometrial ablation.

Symptoms of uterine perforation may include:

* Severe abdominal pain
* Heavy vaginal bleeding
* Fever
* Nausea and vomiting

If you suspect that you have a uterine perforation, it is essential to seek medical attention immediately. Your healthcare provider will perform a physical examination and order imaging tests such as ultrasound or CT scan to confirm the diagnosis and determine the extent of the damage. Treatment options may include:

1. Observation: In mild cases, the body may be able to heal on its own without any intervention.
2. Surgery: Depending on the severity of the perforation, surgical repair or removal of the damaged tissue may be necessary.
3. Antibiotics: If there is an infection, antibiotics will be prescribed to treat it.
4. Blood transfusions: In cases where there is significant bleeding, blood transfusions may be required.

Prevention of uterine perforation is crucial, and it involves proper training and use of instruments during surgery or delivery, as well as careful monitoring of the patient's condition during these procedures.

Symptoms of PID may include:

* Abdominal pain
* Fever
* Heavy vaginal discharge with a strong odor
* Pain during sex
* Painful urination

PID can be diagnosed through a combination of physical examination, medical history, and diagnostic tests such as pelvic exams, ultrasound, or blood tests. Treatment typically involves antibiotics to clear the infection, and may also involve hospitalization for severe cases. In some cases, surgery may be necessary to repair any damage caused by the infection.

Preventive measures for PID include:

* Safe sexual practices, such as using condoms and avoiding sexual intercourse during outbreaks of STIs
* Regular gynecological exams and screening for STIs
* Avoiding the use of douches or other products that can disrupt the natural balance of bacteria in the vagina.

Symptoms of salpingitis may include:

* Pain in the lower abdomen
* Fever
* Abnormal vaginal bleeding or spotting
* Abdominal tenderness
* Nausea and vomiting

Diagnosis of salpingitis is typically made through a combination of physical examination, medical history, and diagnostic tests such as pelvic ultrasound, endometrial biopsy, and laparoscopy. Treatment usually involves antibiotics to clear up any underlying infections, as well as pain management and other supportive measures. In some cases, surgery may be necessary to remove the affected fallopian tube or tubes.

Salpingitis can have serious complications if left untreated, such as chronic pelvic pain, infertility, and ectopic pregnancy (when an embryo implants outside of the uterus). Therefore, it is important for women who experience any symptoms of salpingitis to seek medical attention promptly.

Symptoms of a uterine hemorrhage may include:

* Vaginal bleeding that may be heavy or light in flow
* Pain in the lower abdomen
* Pain during sexual activity
* Spotting or bleeding between menstrual periods
* Unusual discharge from the vagina

If you experience any of these symptoms, it is important to seek medical attention as soon as possible. Uterine hemorrhages can be diagnosed through a physical examination and imaging tests such as ultrasound or MRI. Treatment depends on the underlying cause of the bleeding, but may include medications to control bleeding, surgery to remove fibroids or polyps, or hysterectomy in severe cases.

It is important to note that while uterine hemorrhages can be managed with appropriate medical care, they can also be life-threatening if left untreated. Seeking prompt medical attention and following the advice of your healthcare provider are crucial to preventing complications and ensuring a successful outcome.

Actinomycosis is often difficult to diagnose because the symptoms are non-specific and can mimic other conditions, such as cancer or tuberculosis. A definitive diagnosis requires a combination of clinical findings, radiologic imaging, and microbiological cultures. Treatment usually involves long-term antibiotics, surgical drainage of abscesses, and management of complications.

Actinomycosis can affect people of all ages, but it is more common in adults and rarely seen in children. The infection can be acquired through direct inoculation of the bacteria into the skin or mucous membranes, or through hematogenous spread from a primary site of infection.

The risk factors for developing actinomycosis include poor oral hygiene, dental procedures, surgical trauma, and exposure to contaminated soil or water. The infection can also be associated with underlying conditions such as immunosuppression, diabetes, and chronic lung disease.

In conclusion, actinomycosis is a rare and chronic bacterial infection that can affect various parts of the body, causing inflammation and formation of abscesses. It can be difficult to diagnose and treat, and requires a comprehensive approach involving antibiotics, surgery, and management of complications.

Causes of Menorrhagia

There are several potential causes of menorrhagia, including:

1. Hormonal imbalance: Hormonal changes can lead to an imbalance in the uterus, causing excessive bleeding.
2. Uterine fibroids: These noncancerous growths in the uterus can cause heavy bleeding during menstruation.
3. Adenomyosis: This condition occurs when tissue similar to the lining of the uterus grows into the muscle of the uterus, leading to heavy bleeding.
4. Endometrial polyps: These are growths that can develop on the lining of the uterus and cause heavy bleeding.
5. Thyroid disorders: Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can cause menorrhagia.
6. Pelvic inflammatory disease (PID): This is an infection of the reproductive organs that can cause scarring and lead to heavy bleeding.
7. IUDs: Intrauterine devices (IUDs) can cause heavy bleeding, especially during the first few months after insertion.
8. Medications: Certain medications such as anticoagulants and anti-inflammatory drugs can increase the risk of menorrhagia.
9. Bleeding disorders: Women with bleeding disorders, such as von Willebrand disease or platelet dysfunction, may experience heavy menstrual bleeding.
10. Cancer: In rare cases, menorrhagia can be a symptom of uterine cancer.

Symptoms of Menorrhagia

The primary symptom of menorrhagia is heavy menstrual bleeding that lasts for more than 7 days or bleeds that are heavier than usual. Other symptoms may include:

1. Soaking through sanitary products every hour or two
2. Using double sanitary products (e.g., a pad and a tampon) to control bleeding
3. Bleeding that lasts for more than 7 days
4. Menstrual blood clots larger than a quarter
5. Painful menstruation (dysmenorrhea)
6. Passing large blood clots during bowel movements or urination
7. Fatigue, dizziness, or fainting due to anemia
8. Weakness or shortness of breath

Diagnosis and Treatment of Menorrhagia

If you experience any of the symptoms of menorrhagia, it is important to see a healthcare provider for proper diagnosis and treatment. The healthcare provider will perform a physical examination and may order one or more of the following tests to determine the cause of heavy menstrual bleeding:

1. Complete Blood Count (CBC) to check for anemia and other blood abnormalities
2. Blood smear examination to look for abnormal cells or blood clotting disorders
3. Ultrasound to evaluate the uterus and ovaries
4. Endometrial biopsy to examine the lining of the uterus
5. Hysteroscopy to visualize the inside of the uterus
6. Laparoscopy to evaluate the pelvic organs

Treatment for menorrhagia depends on the underlying cause and may include:

1. Medications such as hormonal contraceptives, nonsteroidal anti-inflammatory drugs (NSAIDs), or iron supplements to control bleeding and anemia
2. Surgical procedures such as endometrial ablation or hysterectomy in severe cases that do not respond to other treatments
3. Lifestyle changes such as avoiding caffeine, alcohol, and spicy foods, as well as taking regular exercise and maintaining a healthy diet
4. Hormone replacement therapy (HRT) to regulate hormonal imbalances
5. Platelet transfusions or blood transfusions in cases of severe bleeding

It's important to note that menorrhagia can be a symptom of a more serious underlying condition, so it's essential to seek medical attention if you experience any of the following:

1. Prolonged or heavy menstrual bleeding (more than 7 days)
2. Bleeding between periods or after sex
3. Painful periods or difficulty using tampons
4. Fever, chills, or vomiting during menstruation
5. Unusual vaginal discharge or odor
6. Abdominal pain or bloating

Early diagnosis and treatment can help manage symptoms and prevent complications of menorrhagia, such as anemia, fatigue, and infertility.

Foreign-body migration refers to the movement or migration of a foreign object or material within the body over time. This can occur after a surgical procedure, injury, or other medical intervention where a foreign object is introduced into the body. The term "foreign body" includes any object or material that is not naturally present within the body, such as implants, sutures, staples, and other medical devices.

The migration of a foreign body can occur due to various factors, including:

1. Mechanical forces: Movement of the body, such as during exercise or daily activities, can cause the foreign object to shift position or migrate to another part of the body.
2. Biological forces: The body's natural healing processes and inflammatory responses can cause the foreign object to move or change shape over time.
3. Chemical forces: Corrosion or degradation of the foreign material can lead to its migration within the body.
4. Cellular forces: Cells in the body can surround and interact with the foreign object, leading to its movement or displacement.

The migration of a foreign body can have significant clinical implications, including:

1. Pain and discomfort: The movement of a foreign object within the body can cause pain, discomfort, and inflammation.
2. Infection: The migration of a foreign object can increase the risk of infection, particularly if the object is made of a material that is susceptible to bacterial growth.
3. Organ damage: If the migrated foreign object damages surrounding tissues or organs, it can lead to serious complications and long-term health problems.
4. Revision surgery: In some cases, the migration of a foreign body may require revision surgery to remove or reposition the object.

To prevent foreign-body migration, medical professionals use various techniques, such as:

1. Implant fixation: Implants can be fixed in place using bone screws, sutures, or other fixation devices to minimize their movement.
2. Biocompatible materials: Using biocompatible materials for implants and other medical devices can reduce the risk of foreign-body reaction and migration.
3. Proper surgical technique: Surgeons must use proper surgical techniques when inserting foreign objects into the body, such as using a sterile environment and appropriate insertion angles.
4. Postoperative care: Proper postoperative care, including antibiotics and pain management, can help prevent complications and promote healing.

Overall, preventing the migration of foreign bodies is essential to ensure successful medical outcomes and minimize the risk of complications.

Also known as: Menstrual Disorders, Menstrual Abnormalities, Dysmenorrhea, Amenorrhea, Oligomenorrhea, Polymenorrhea.

"Popular contraceptive device Mirena target of lawsuits in Canada, U.S". CTV. 21 May 2014. Archived from the original on 26 ... Various thread collector devices or simple forceps may then be used to try to grasp the device through the cervix. In the rare ... WHO (2010). "Intrauterine devices (IUDs)". Medical Eligibility Criteria for Contraceptive Use (4th ed.). Geneva: Reproductive ... 1988). "New insights on the mode of action of intrauterine contraceptive devices in women". Fertil Steril. 49 (5): 768-773. doi ...
An intrauterine device (IUD), also known as intrauterine contraceptive device (IUCD or ICD) or coil, is a small, often T-shaped ... Grimes, D.A. (2007). Hatcher, R.A.; Nelson, T.J.; Guest, F.; Kowal, D. (eds.). "Intrauterine Devices (IUDs)". Contraceptive ... Copper devices have a failure rate of about 0.8% while hormonal (levonorgestrel) devices fail about 0.2% of the time within the ... "IUD (intrauterine device)". Contraception guide. NHS Choices. Retrieved 2 March 2014. the intrauterine device, or IUD ( ...
Tone A (2001). Devices & Desires: A History of Contraceptives in America. New York: Hill and Wang. ISBN 978-0-8090-3817-6. ... to physicians as a contraceptive. Although the FDA approved the first oral contraceptive in 1960, contraceptives were not ... Non-hormonal contraceptive methods, such as the Copper IUD or condoms, should be the first-line contraceptive choice for these ... Oral contraceptives should not be used as an initial treatment for female athlete triad. While combined oral contraceptives are ...
"The contraceptive patch" (in French). "Male condom" (in French). "Spermicides" (in French). "Intrauterine device" (in French ... The contraceptive implant is a small stick put in place under the skin. The implant contains the same hormones as contraceptive ... The French government will provide access to birth control pills, intrauterine devices, contraceptive patches and injectable ... There are many types of contraceptive methods available in France. All contraceptives are obtained by medical prescription ...
A contraceptive sponge set inside its open package. The current intrauterine devices (IUD) are small devices, often 'T'-shaped ... Emergency contraceptive methods are medications (sometimes misleadingly referred to as "morning-after pills") or devices used ... Grimes DA (2007). "Intrauterine Devices (IUDs)". In Hatcher RA, Nelson TJ, Guest F, Kowal D (eds.). Contraceptive Technology ( ... These include barrier methods, hormonal methods, implanted devices, emergency contraceptives, and sterilization procedures. In ...
"Contraceptive devices: subcutaneous delivery systems". Expert Review of Medical Devices. 5 (5): 623-637. doi:10.1586/17434440.5 ... These formulations are used as emergency contraceptives, normal contraceptives, or in menopausal hormone therapy for the ... Levonorgestrel is currently the most androgenic progestin that is used in contraceptives, and contraceptives containing ... Committee on the Relationship Between Oral Contraceptives and BreastCancer (1 January 1991). Oral Contraceptives and Breast ...
Grimes, David (2007). "Intrauterine Devices (IUDs)". In Hatcher, Robert A.; et al. (eds.). Contraceptive Technology (19th rev. ... the combined oral contraceptive pill (COCP). The group Pharmacists for Life has called for a large-scale clinical trial to ... to the effectiveness of these devices. However, more recent evidence, such as tubal flushing studies indicates that IUDs work ... "Early pregnancy factor as a monitor for fertilization in women wearing intrauterine devices". Fertility and Sterility. 37 (2): ...
... he also sold contraceptive devices. The book, cheaply produced, had reached a 14th edition by 1876; in all there were 35 ...
Chinnatamby, S. (September 25, 1965). Intrauterine Contraceptive Device and Population. British Medical Journal, 2, 5464, 756. ... In 1964, she led trials of intrauterine devices at Colombo North Hospital, and in 1968, she began trials of Depo-Provera. In ... Siva Chinnatamby (c.1921/3 - 2000) was a Sri Lankan obstetrician who pioneered the use of modern contraceptives in the country ... Chinnatamby, S. (November 01, 1971). A Comparison of the Long-Acting Contraceptive Agents Norethisterone Oenanthate and ...
Grimes, David (2007). "Intrauterine Devices (IUDs)". In Hatcher, Robert A.; et al. (eds.). Contraceptive Technology (19th rev. ... "Mechanisms of the Contraceptive Action of Hormonal Methods and Intrauterine Devices (IUDs)". Family Health International. 2006 ... Hormonal contraceptives have a possible effect of preventing implantation of a blastocyst, as discussed previously. Use of ... Some pro-choice groups have expressed concern that the movement to recognize hormonal contraceptives as abortifacient will also ...
... intrauterine contraceptive device-associated infection; pelvic inflammatory disease, which may include pelvic cellulitis and ... Long bones osteomyelitis is often caused by trauma, hematogenic spread, or the presence of a prosthetic device.[citation needed ... and Eubacterium nodatum are often recovered in infections associated with intrauterine devices. Mobiluncus spp. can be ...
... and expulsion of the device. The one-year combined hormonal contraceptive ring is also known as Annovera. It is a silicone ... When compared to other forms of contraception (combined oral contraceptives, contraceptive patch), the contraceptive vaginal ... Meyer S (August 2009). "Contraceptive patch and vaginal ring vs. combined oral contraceptives". American Family Physician. 80 ( ... A contraceptive vaginal ring is a type of hormonal insert that is placed in the vagina for the purpose of birth control. The ...
They include injections, intrauterine devices (IUDs), and subdermal contraceptive implants. They are the most effective ... Nonhormonal intrauterine device with copper (US - ParaGard) Subdermal contraceptive implant (US - Nexplanon/Implanon/Implanon ... Progestogen-only injectable contraceptive Combined injectable contraceptive The effectiveness of LARC methods has been shown to ... found that the risk of contraceptive failure for those using oral contraceptive pills, the birth control patch, or the vaginal ...
A condom is a contraceptive device. Condom may also refer to: Jean Condom (born 1960), French international rugby union player ...
"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". Am J Obstet Gynecol. 181 (5 Pt 1): ... The only contraceptive measures that does so are latex or polyurethane condoms. The contraceptive vaginal ring has a failure ... The combined hormonal contraceptive vaginal ring is self-administered once a month. Leaving the ring in for three weeks slowly ... Rings can be removed prior to intercourse, but, in the case of the contraceptive NuvaRing, only for one to three hours to ...
"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". American Journal of Obstetrics and ... The Ortho Evra contraceptive patch and the Evra contraceptive patch are both intended to gradually release into the systemic ... Trussell J (2007). "Contraceptive Efficacy". In Hatcher RA, et al. (eds.). Contraceptive Technology (19th rev. ed.). New York: ... Contraceptive effectiveness of the patch or any other hormonal contraceptive may be reduced significantly if administered ...
Stein R (21 September 2015). "FDA Revisits Safety Of Essure Contraceptive Device". NPR. Retrieved 21 September 2015. Mao J, ... comparing the effectiveness and safety of the device with other surgical contraceptive methods. Women and doctors were required ... Essure was a device for female sterilization. It is a metal coil which when placed into each fallopian tube induces fibrosis ... The device is featured in the 2018 Netflix documentary The Bleeding Edge. A 2015 review found the effectiveness of Essure is ...
Shortly thereafter Jaime Zipper, in Chile, introduced the idea of adding copper to the devices to improve their contraceptive ... Most copper devices consist of a plastic core that is wrapped in a copper wire. Many of the devices have a T-shape similar to ... Intrauterine device (IUD) with copper, also known as intrauterine coil, is a type of intrauterine device which contains copper ... Some barrier contraceptives protect against STIs. Hormonal contraceptives reduce the risk of developing pelvic inflammatory ...
He is best known for his contribution to the development of oral contraceptive pills, nicknamed the "father of the pill". Carl ... ISBN 978-0-300-08943-1. Tone, Andrea (2001). Devices and Desires. New York: Hill and Wang, A Division of Farrar, Straus and ... His preparation was first administered as an oral contraceptive to animals by Gregory Goodwin Pincus and Min Chueh Chang and to ... This became part of one of the first successful combined oral contraceptive pills, known colloquially as the birth-control pill ...
Malthusian belt: A contraceptive device worn by women. When Huxley was writing Brave New World, organizations such as the ... In the novel, the eponymous character devises the contraceptive techniques (Malthusian belt) that are practiced by women of the ...
Highly effective contraceptives, such as intrauterine devices (IUDs), are underused in the United States. Increasing use of ... oral contraceptives (the pill), with estrogen and progestin, oral contraceptives with progestin only, oral contraceptives, ... Cost to the user is one factor preventing many US women from using more effective contraceptives. Making contraceptives ... 2011 interim final rule on health insurance coverage with no cost sharing for FDA-approved contraceptives and contraceptive ...
He patented an Intra uterine contraceptive device named Copper Omega. Also, he developed two more medical devices: the Emmett ...
Owning and using contraceptive devices and pills was not prohibited. However, from 1935, it was illegal to sell or to import ... laden with contraceptive devices, into a statement on the illogicality of the law. This provoked criticism from the Roman ... During this time a loophole was used, where a device such as a condom could not be "offered for sale", but a citizen could be " ... "Sexual Health or Contraceptive Evangelism?". Northern Ireland Pharmacy in Focus. January 2007. p. 25. Archived from the ...
The SILCS diaphragm, a "one size fits most" contraceptive device. The device differs from traditional latex diaphragms in that ... Alejandro Zaffaroni Health Award for its work on the Uniject device, a sterile pre-filled, single-use syringe. Since 2005, PATH ... Founded in 1977 as the Program for the Introduction and Adaptation of Contraceptive Technology with a focus on family planning ... PATH is best known for developing and adapting technologies, such as improved vaccination devices and new tools to prevent ...
She enthusiastically promotes condoms as the best all-around contraceptive device. After discussing the merits of prophylactics ... Krause has not been daunted by Cuban male's abhorrence of contraceptive responsibility. ...
Thiery 1997, p. 9. Thiery 1997, p. 4. Margulies, Lazar (17 August 1965). "Coil Spring Intra-Uterine Contraceptive Device and ... He is best known for developing a type of safe Intrauterine device (IUD) made of plastic. Margulies was born in Galicia, which ... Coil Spring Intra-Uterine Device and Method of Using (patent) (Articles with short description, Short description is different ... Thiery, M. (March 1997). "Pioneers of the Intrauterine Device" (PDF). The European Journal of Contraception and Reproductive ...
"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". Am J Obstet Gynecol. 181 (5 Pt 1): ... Goebelsmann U (1986). "Pharmacokinetics of Contraceptive Steroids in Humans". In Gregoire AT, Blye RP (eds.). Contraceptive ... Combined injectable contraceptives (CICs) are a form of hormonal birth control for women. They consist of monthly injections of ... vaginal hormonal contraceptive use, „Contraception" 2011, t. 84, p. e2-3 R. L. Birtch, O. A. Olatunbosum, R. A. Pierson, ...
"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". American Journal of Obstetrics and ... Progestogen-only contraception Combined oral contraceptive pill Contraceptive patch Contraceptive vaginal ring "FSRH Clinical ... The FDA first approved the oral contraceptive in 1960. The first oral contraceptive contained 100 to 175 µg of estrogen and 10 ... WHO Medical eligibility criteria for contraceptive use (2015) p. 7 WHO Medical eligibility criteria for contraceptive use (2015 ...
"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices". American Journal of Obstetrics and ... Goebelsmann U (1986). "Pharmacokinetics of Contraceptive Steroids in Humans". In Gregoire AT, Blye RP (eds.). Contraceptive ... Additionally, unlike most other hormonal contraceptives, DMPA's contraceptive effectiveness is not affected by enzyme-inducing ... Contraceptive Technology, 17th revised edition (1998) Adopted in 1998 by the FDA for its current Uniform Contraceptive Labeling ...
Tone, Andrea (2001). Devices & Desires: A History of Contraceptives in America. New York: Hill and Wang. "Prospects of Mankind ... In 1960, the Food and Drug Administration approved the combined oral contraceptive pill, which was made available in 1961. This ...
Contraceptive measures that lead to male sterility, are not ever permitted for their interfering with a man's obligation, only ... or an intrauterine device) is preferred by most authorities. Fertility awareness methods (modern improvements over the rhythm ... The Midrash of Genesis speaks of the origins of oral contraceptives: "In the early time of creation, in the time of Lemech, a ... An innovative use of the combined oral contraceptive pill in Judaism is employed by some young brides. The laws of family ...
Medical devices used for biopsy of the cervix include punch forceps. Colposcopic impression, the estimate of disease severity ... Long-term use of oral contraceptives is associated with increased risk of cervical cancer in women who have had HPV. Women who ... oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature". ... have used oral contraceptives for 5 to 9 years have about three times the incidence of invasive cancer, and those who used them ...
... such as the contraceptive implant or intrauterine device (IUD), both of which can be inserted immediately after delivery while ... Postplacental insertion of intrauterine devices". Contraception (published January 2018). 97 (1): 2-13. doi:10.1016/j. ...
... intrauterine devices (IUDs), and contraceptive patches), or throwing away (or simply lying about the consumption of) oral ... not informing a partner after ceasing the use of female-controlled contraception or removing contraceptive devices, and not ... contraceptive implants, or contraceptive injections), and assessing their patient's safety prior to notifying partners about ... Birth control Contraceptive security Domestic violence and pregnancy Forced marriage Forced pregnancy Forced abortion Paternity ...
United States v. Jones, 565 U.S. 400 (2012) Attaching a GPS device to a vehicle and then using the device to monitor the ... and advertisement of contraceptives to both adults and minors are unconstitutional. Planned Parenthood v. Casey, 505 U.S. 833 ( ... cannot be liable for contributory copyright infringement for the potential uses by their purchasers because the devices are ...
This belief leads to the rape myth - even when women resist sexual advances they are using it merely as a seductive device. On ... In 1992, the government of Japan justified its continued refusal to allow oral contraceptives to be distributed in Japan on the ...
2014) in their fight to exempt themselves from having to pay for four different drugs and devices they deemed as abortifacients ... contraceptive mandate on employer-paid health insurance coverage of contraception, which had at the time been consolidated into ...
... millions of intrauterine contraceptive devices were exported to poor countries although they were known to cause infections and ...
"Why the Oral Contraceptive Is Just Known as "The Pill"". Smithsonian Magazine. Archived from the original ... Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws ... The history of the development of oral contraceptives is thus closely tied to the birth control movement and the efforts of ... "FDA's Approval of the First Oral Contraceptive, Enovid". Food and Drug Administration. Archived from the original on 23 July ...
The guerrillas were issued contraceptive devices at a clinic in Morelia which the government had helped found and fund. Nor was ... the encouragement and distribution of contraceptives restricted to the guerrillas themselves. Marcos believed that one of the ...
In November 2019, Baker signed into law a bill banning the use of handheld electronic devices while driving. The bill went into ... when the Trump administration issued new regulations allowing insurers and employers to opt out of contraceptive mandates, ... Zimmerman, Rachel (April 13, 2017). "New WPI Center Aims To Accelerate Smart Medical Device Production". WBUR. Retrieved June ... Charlie Baker signs law banning minors from using tanning devices". Advance Publications. Retrieved May 19, 2018 ...
Fetal Acoustic Stimulation Device, patent ES2546919B1, granted 29 September 2015 to Luis y Pallarés Aniorte and Maria Luisa ... Shafik, Ahmed (May 1992). "Contraceptive efficacy of polyester-induced azoospermia in normal men". Contraception. 45 (5): 439- ... Economics: Kuo Cheng Hsieh, for patenting a device to catch bank robbers by ensnaring them in a net. Linguistics: Juan Manuel ... US 7255627 "Garment device convertible to one or more facemasks" Bertenshaw, C.; Rowlinson, P. (2009). "Exploring Stock ...
As a final note, Zaphod explains that his great-grandfather is "the Fourth" due to an accident with a contraceptive and a time ... Having wasted most of the period of time failing to create a cloaking device, he hired a company to simply remove the mountain ... Mincefriend became very wealthy when he patented and successfully marketed a device he had seen in a history book: the ... This was due to an "accident with a contraceptive and a time machine". The great-grandfather of Zaphod Beeblebrox, Zaphod ...
... or other devices that release the active ingredient(s) over a longer period). Some of these agents are being developed for ... it remains a contraceptive option for women at low risk. Efforts are underway to develop safe and effective topical ...
... as an effective device against both black magic and the evil eye. It finds many household uses around the world as well. It is ... Abortifacients and Contraceptives in Ancient Greek Medicine and Their Recent Scientific Appraisal". Pharmacy in History. 51 (2 ...
It was conceived in 2012 as a device to generate public awareness concerning the rising number of deaths due to domestic ... Turkish women have the right to freely exercise abortions in the first 10 weeks of pregnancy and the right to contraceptive ...
Controversy around the app as a contraceptive device grew stronger after numerous women in Stockholm reported unplanned ... Other medical devices and implements produced in the femtech category may or may not use an internet connection. Joylux is a ... "Swedish regulator says contraceptive app works as advertised". Engadget. Retrieved 2020-10-02. Holley, Peter (19 October 2017 ... iPulse Medical sells a menstrual pain relief wearable device. Swedish company Natural Cycles was the first to receive official ...
Progestin is present in the combined oral contraceptive pill and the hormonal intrauterine device (IUD). Combined oral ... This risk reduction continues for at least fifteen years after contraceptive use has been stopped. Obese women may need higher ... contraceptives reduce risk more the longer they are taken: by 56% after four years, 67% after eight years, and 72% after twelve ...
... a long-acting reversible hormonal contraceptive device Jus (disambiguation) This disambiguation page lists articles associated ...
... earlier permitted termination of the pregnancy by only a married woman in the case of failure of contraceptive method or device ... As a fallout of lockdown due to COVID-19, over 20 million couples in the country were deprived from availing contraceptives and ... services a week before the lockdown and issued a guidance advising that sterilizations and intrauterine contraceptive devices ( ... The proposal for amendment includes making contraceptive failure applicable for all women and their partners as with other ...
Neither barrier device use (such as condoms) nor more vigilant STI testing and vaccination can fully eliminate such risk, but ... ISBN 978-0-80183-935-1. Hatcher, Robert Anthony; M.D, Anita L. Nelson (2007). Contraceptive Technology. Ardent Media. pp. 297- ...
Redberg RF, Dhruva SS (June 2011). "Medical device recalls: get it right the first time: Comment on "Medical device recalls and ... Ronio Caryn Rabin (May 3, 2015). "Long-Term Data on Complications Adds to Criticism of Essure Contraceptive Implant". The New ... Based on FDA data, the authors determined that most of the devices that were high-risk recalls had never been studied in ... "A Delicate Balance: FDA and the Reform of the Medical Device Approval Process". Gardiner Harris (April 8, 2009). "F.D.A. to ...
Contraceptive condoms are generally made of latex, and are designed for contraception and preventing spread of sexually ... A conception device is a medical device which is used to assist in the achievement of a pregnancy, often, but not always, by ... The device comprises a hollow, vertically supported column, having a closed lower end, and an open upper end. This device ... The device consists of two shaped flanges which are inserted into the vagina and can be opened and locked in the open position ...
They showed that silicone breast implants did not cause connective tissue diseases or gammopathies; that oral contraceptives ... one medical device, and published over 400 papers, books, book chapters,etc. Henkel 2009. New York Times 1991. Liang et al. ... did not prevent rheumatoid arthritis; and that women risked developing lupus from oral contraceptives and post-menopausal ...
These rates are roughly equivalent to the effectiveness of long-acting reversible contraceptives such as intrauterine devices ... "Trends in Contraceptive Use Worldwide" (PDF). Department of Economic and Social Affairs, Population Division, United Nations. ... "Contraceptive Use in the United States". Guttmacher Institute. 4 August 2004. Retrieved 9 July 2019. Wikimedia Commons has ... EngenderHealth (Firm) (2002). Contraceptive sterilization : global issues and trends. Ross, John A., 1934-. New York, NY: ...
The contraceptive use rate in the country is about 66.9% a little high compared to other countries. Mexico contains a variety ... IUDs (Intrauterine Devices) are the most popular forms of contraception, these will be inserted during these visits. ... still there are some similar beliefs across the board about the harmful effects of contraceptives. Especially since fertility ...
The most common surgical technique involves dilating the cervix and using a suction device. Birth control, such as the pill or ... The unsafe abortion rate in developing countries is partly attributable to lack of access to modern contraceptives; according ... intrauterine devices, can be used immediately following abortion. When performed legally and safely on a woman who desires it, ... to the Guttmacher Institute, providing access to contraceptives would result in about 14.5 million fewer unsafe abortions and ...
Since 2016, he has been working alongside Memphasis to develop "Felix", a device which uses a patented cell separation ... Besides discovering oxidative stress, Aitken also improved the male contraceptive vaccine in later years. His paper in the ... This research provided the foundation for designing a long-lasting and reversible form of contraceptives, providing an ... Their study included developing the potential contraceptive potential of ZP3 peptides and other chemical compositions of these ...
Summary of classifications for hormonal contraceptive methods and intrauterine devices*. Condition. Cu-IUD. LNG-IUD. Implants. ... Hormonal contraceptives and intrauterine devices do not protect against sexually transmitted diseases (STDs), including human ... CDC Contraceptive Guidance for Health Care Providers * US Medical Eligiblity Criteria (US MEC) for Contraceptive Use ... 1 = A condition for which there is no restriction for the use of the contraceptive method.. 2 = A condition for which the ...
Barrier contraceptives and spermicides : their role in family planning care  World Health Organization (‎World Health ... Medical eligibility criteria for contraceptive use : 2008 update  World Health Organization (‎World Health Organization, 2008 ... Pharmacological models in contraceptive development : animal toxicity and side-effects in man, proceedings of a meeting ... Contraceptive introduction reconsidered : a review and conceptual framework / Joanne Spicehandler and Ruth Simmons on behalf of ...
... August 2nd, 2012 Medgadget Editors Ob/Gyn, ... contraceptive device that was designed to solve a few of the possible implantation downsides of current offerings, such as ... diameter larger than the cervical canal and has superior flexibility and minimal tissue protrusion compared to current devices ...
Long-acting reversible contraceptive (LARC) use, including subdermal hormonal implants and intrauterine devices (IUDs), has ... Incidence of Sexually Transmitted Infections Before and After Insertion of an Intrauterine Device or Contraceptive Implant, ... Incidence of Sexually Transmitted Infections Before and After Insertion of an Intrauterine Device or Contraceptive Implant, ... Incidence of Sexually Transmitted Infections Before and After Insertion of an Intrauterine Device or Contraceptive Implant, ...
Contraceptive Devices: An Overview. By condomman69 Contraceptive Devices: An Overview. With numerous contraceptives available ... Other devices with similar action are the contraceptive foam and the contraceptive suppositories. Though convenient to use, ... It is a device made of latex and, after coating with spermicide, is inserted into the vagina and up into the cervix. It is an ... This device must not remain in the body for more than 48 hours, to avoid toxic shock syndrome, and would need to be replaced ...
Another 24 women who had an intrauterine contraceptive device inserted at the end of the abortion procedure were studied as ... The changes in coagulation parameters were studied in 24 women who started using microdose combined oral contraceptives ... Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion P ... Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion P ...
The BBC reported that the judge decided that an implanted contraceptive device would be in the best interests of the woman, who ... Denver Newsroom, Apr 23, 2020 / 02:35 pm (CNA).- A British judges order requiring a contraceptive device be implanted in a ... "On this basis, the judge concluded that an intrauterine contraceptive device (IUD) would be in the womans best interests," he ... UK court order requiring contraceptive device for disabled woman is deeply problematic, says bioethicist. ...
Effect of an intrauterine contraceptive device on uterine motility in the rat. ... Effect of an intrauterine contraceptive device on uterine motility in the rat. Journal Article (Journal Article) ...
Contraceptive pill. The combined contraceptive pill is taken daily. It contains two hormones, estrogen and progestin. The ... The intrauterine device (IUD). The intrauterine device (IUD), or coil, is a small, flexible T-shaped device that is placed in ... A contraceptive sponge is inserted into the vagina. It has a depression to hold it in place over the cervix. Foam is placed ... The contraceptive vaginal ring is a flexible, plastic ring that releases a low dose of progestin and estrogen over 3 weeks. It ...
Contraceptive Devices, Female -- statistics & numerical data ✖Remove constraint Subjects: Contraceptive Devices, Female -- ...
... There are two types of intrauterine device (IUD) used in Well Woman ... Whether you have a Mirena or a copper coil fitted, the device must be put in by a specially trained doctor. The device is ... and a device containing Both are small T - shaped devices that must be inserted into your womb by a trained doctor. Once in ... Devices.pdf S t r a n d h o t e l G e o r G S h ö h e , n o r d e r n e yWellness auf der Höhe der Zeit können ...
Insertion of intrauterine contraceptive device prices and locations Enquire now Insertion of intrauterine contraceptive device ... Home Treatments Gynaecology Insertion of intrauterine contraceptive device. Search Practice Plus Group. Search On this page. ... Insertion of intrauterine contraceptive device. Choose the right path for your individual needs.. At Practice Plus Group we ... offer fast access to high-quality insertion of intrauterine contraceptive device procedure via self-pay, insured and NHS routes ...
Local production of contraceptives. by United Nations Population Fund.. Series: Evaluation report (United Nations Population ... The costs of contraceptive social marketing programs implemented through the SOMARC Project : special study no. 1, June 1992 / ... Barrier contraceptives and spermicides : their role in family planning care. by World Health Organization. ... Pharmacological models in contraceptive development : animal toxicity and side-effects in man, proceedings of a meeting ...
Long-acting reversible contraceptives (LARCs). Intrauterine device (IUD). A small, T-shaped device that a provider inserts into ... FastStats: Contraceptive Use (National Center for Health Statistics) * Key Statistics from the National Survey of Family Growth ... Contraceptive sponge. A small sponge that you put into the vagina to cover the cervix (the opening of the uterus). The sponge ... Contraceptive patch. A patch that a woman puts on her skin each week. The patch releases hormones into the bloodstream.. ...
Immediate postpartum intrauterine contraceptive device utilization and associated factors among women who gave birth in public ... The evidence on utilization of immediate postpartum intrauterine contraceptive devices (IPPIUCDs) and its associated factors ... and integrating standard counseling on immediate postpartum intrauterine device (IPPIUD) during antenatal care, and the ...
Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. ... Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. ... Acceptor Characteristics, Age Factors, Contraception, Contraceptive Methods, Correlation Studies, Demographic Factors, Diseases ... Intrauterine Devices, Copper, Middle Aged, Parity, Pelvic Inflammatory Disease ...
LEADER EMERGENCY CONTRACEPTIVE LEVONORGESTREL (levonorgestrel) tablet. NDC Code(s): 70000-0600-1 *Packager: Cardinal Health 110 ... KYLEENA (levonorgestrel) intrauterine device. NDC Code(s): 50419-424-01, 50419-424-08, 50419-424-71 *Packager: Bayer HealthCare ... SEARCH RESULTS for: Progestin-containing Intrauterine Device [Drug Class] (165 results) *Share : JavaScript needed for Sharing ...
Long-acting reversible contraceptives (LARCs). Intrauterine device (IUD). A small, T-shaped device that a provider inserts into ... FastStats: Contraceptive Use (National Center for Health Statistics) * Key Statistics from the National Survey of Family Growth ... Contraceptive sponge. A small sponge that you put into the vagina to cover the cervix (the opening of the uterus). The sponge ... Contraceptive patch. A patch that a woman puts on her skin each week. The patch releases hormones into the bloodstream.. ...
This comprehensive communication campaign focuses on raising awareness of contraceptive options as well as drawing attention to ... developed this digital toolkit to help you communicate with beneficiaries about contraceptive care with TRICARE. ... Could state abortion laws affect the use of IUDs (Intrauterine Devices)? A: DOD will continue providing IUDs and other ... Walk-In Contraceptive Services Toolkit , Womens Health , Contraceptive Care , Contraceptive Care Toolkit , Reproductive Health ...
Use of oral contraceptives or an intrauterine device. All contraceptive methods lead to an overall lower risk of pregnancy and ... Data from the Contraceptive CHOICE Project demonstrated a relative risk of 3.16 for ectopic pregnancy in women not using any ... However, among cases of contraceptive failure, women at increased risk of ectopic pregnancy compared with pregnant controls ... progesterone-only contraception and progesterone intrauterine devices (IUDs) have been associated with an increased risk of ...
The Essure Contraceptive Device is a medical device touted as the only nonsurgical sterilization device. This solution seems ... Essure Contraceptive Device The Target Of Legislation For FDA Ban. Nov 13, 2015 , Defective Medical Devices, Drug Side Effects ... like the Essure contraceptive device. If you have been implanted with an Essure device, you may be eligible for compensation ... Such is the case with the Essure device, as many of the women who suffer serious injury with the implanted device end up ...
Intrauterine contraceptive devices Intrauterine contraceptive device: these are also called "coils" and are inserted into the ... As well as being able to tell you how your condition can affect the contraceptive you take, they can advise you what methods ... The side effects of emergency oral contraceptive pills are mild (nausea, breast tenderness, disruption to periods), but there ... The suitability of different contraceptive methods may depend on other illnesses that you have, the medicines that you are ...
Contraceptive devices. *. Broader Terms. *Medical instruments and apparatus. *. Narrower Terms. *Contraceptive drugs ...
Device Classification Name. device, fertility diagnostic, contraceptive, software application 510(k) Number. K202897. ...
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) RFA-HD-19-015. NICHD ... Application focused on the development of molecules or devices that disrupt/perturb the blood-testis and/or blood-epididymal ... Male or female contraceptive development based on nonsteroidal action;. Male and/or female pre-coital on-demand contraception ... If the application proposes a modulation to achieve contraceptive effect that is not validated, the milestones in the R61 phase ...
Contraceptive Agents, Female / therapeutic use* * Cost-Benefit Analysis * Female * Humans * Intrauterine Devices, Medicated* ...
Radiological Case: Removal of Subdermal Contraceptive Device. Applied Radiology August 4, 2023 ...
... and commonly used devices in Puerto Rico.. ¶¶Weighted average cost for generic contraceptive pill (78%, $370/y), injectable (14 ... Highly effective contraceptive methods§§. $666 ($533-$799). Triangular. Moderately effective contraceptive methods¶¶. $417 ($ ... Moderately effective methods include oral contraceptive pills, patches, vaginal rings, and injectable contraceptives. Highly ... intrauterine device; LARC, long-acting reversible contraceptive; NSFG, National Survey of Family Growth; ONDIEH, Office of ...
remove tampons, contraceptive devices, or wound packing. *clean wounds. *drain a pocket of infection (an abscess) ... Two birth control methods, the contraceptive sponge and the diaphragm, have been linked to TSS. ...
  • The evidence on utilization of immediate postpartum intrauterine contraceptive devices (IPPIUCDs) and its associated factors are limited in Ethiopia . (
  • Health-care providers can use the summary table as a quick reference guide to the classifications for hormonal contraceptive methods and intrauterine contraception to compare classifications across these methods ( Box K1 ) ( Table K1 ). (
  • Hormonal contraceptives and intrauterine devices do not protect against sexually transmitted diseases (STDs), including human immunodeficiency virus (HIV), and women using these methods should be counseled that consistent and correct use of the male latex condom reduces the risk for transmission of HIV and other STDs. (
  • Long-acting reversible contraceptive (LARC) use, including subdermal hormonal implants and intrauterine devices (IUDs), has been increasing for almost 2 decades, from 1.5-2.5% of U.S. women of childbearing age in the early 2000s 1,2 to 10.3-14.3% between 2009 and 2015. (
  • Six mothers had a levonorgestrel-releasing IUD and seven others the Nova-T or no hormonal or intrauterine contraceptive. (
  • Emergency contraceptive pills (ECPs), which are hormonal pills which the woman takes as soon as possible after unprotected intercourse. (
  • It is important to know that pregnancy also increases the risk for blood clots, and much more significantly than any hormonal contraceptive. (
  • Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive. (
  • 5. Intrauterine devices: an effective alternative to oral hormonal contraception. (
  • Phase 1: Copayments and cost-shares for long-acting reversible contraceptives services such as placing and removal of IUDs, contraceptive shots, and subdermal contraceptive rods will be waived beginning Nov. 1, 2022. (
  • The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists (ACOG) recommend intrauterine devices (IUDs) and contraceptive implants (Nexplanon) as first-line contraceptive options for sexually active teens based on the effectiveness of these contraceptives and high rates of patient satisfaction. (
  • The downside of this birth control device is the need to use fresh condoms for every sexual act. (
  • Though these inserted contraceptives do afford women control over their sexual lives, it is still best to ask your partners to do their part and use some forms of contraceptives themselves, like the use of condoms. (
  • A study compared prolactin serum concentrations in 40 women using a copper-containing intrauterine device (Copper T, Copper 7 or Soonawalla Y) to those of 20 women who were using condoms or practicing abstinence. (
  • Most-such as birth control pills, vaginal rings, female condoms, and intrauterine devices-rely on the woman. (
  • Between 1 Jan. 2015 and 31 Dec. 2018, 18,691 service women in the study population received an intrauterine device (IUD) and 17,723 received an implant. (
  • In general, among service women who began using LARC (an IUD or a contraceptive implant), incidence rates of STIs did not increase from the year before to the year after insertion. (
  • Just like a contraceptive implant, IUD is reversible. (
  • 16. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. (
  • To increase contraceptive choices, TRICARE is waiving copayments and cost-shares on medical contraception such as long-acting reversible contraceptives (LARCs) and permanent contraception. (
  • For some patients, an intrauterine device may be a good choice for emergency contraception. (
  • In addition to contraception, the devices in the study, titled, Medical Device Approvals Through the Premarket Approval Pathway in Obstetrics and Gynecology From 2000 to 2015: Process and Problems, were approved for things such as reducing menstrual flow and fetal monitoring. (
  • 11. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception. (
  • 13. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception. (
  • As well as being able to tell you how your condition can affect the contraceptive you take, they can advise you what methods are most suited to you. (
  • The suitability of different contraceptive methods may depend on other illnesses that you have, the medicines that you are taking, and your own personal preference. (
  • Two birth control methods, the contraceptive sponge and the diaphragm , have been linked to TSS. (
  • This FOA supports the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in its mission to develop novel, safe and effective contraceptive methods for men and women. (
  • The PCDP is a research program formed to expand research leading to the development of male and female contraceptive methods. (
  • Contraceptives are devices, drugs, or methods for preventing pregnancy either by preventing the fertilization of the female egg by the male sperm or by preventing implantation of the fertilized egg. (
  • 7. Use of contraceptive methods among women with endometrial hyperplasia: a systematic review. (
  • The copper IUD is acceptable to use during breastfeeding as a long-term contraceptive. (
  • The optimal long-term contraceptive method? (
  • The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary research approaches for the development of novel nonsteroidal contraceptive products for men and women that act prior to fertilization. (
  • At Practice Plus Group we offer fast access to high-quality insertion of intrauterine contraceptive device procedure via self-pay, insured and NHS routes. (
  • In women who are breastfeeding, insertion of the device should be after 4 weeks postpartum. (
  • 1 ] A more recent prospective study found a slight increase in the risk of expulsion of intrauterine devices with breastfeeding,[ 2 ] and the American College of Obstetrics and Gynecology recommends that women be counseled that immediate postpartum insertion may have a higher expulsion rate than later insertion. (
  • Milk samples were collected at 10 weeks postpartum before insertion and 6 weeks after insertion of the devices from 21 women in the first study group, 22 in the second study group and 20 women in the control group. (
  • Another barrier birth control device is the sponge, made of polyurethane and is placed on the cervix before the sex act. (
  • A contraceptive sponge is inserted into the vagina. (
  • Effective July 28, 2022, copayment and cost-shares were waived for long-acting reversible contraceptives. (
  • Women of all ages can now get the levonorgestrel emergency contraceptive pill Plan B One-Step and its generic versions without a prescription. (
  • 14. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer. (
  • 18. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms. (
  • 19. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. (
  • It is an effective birth control device in such as way that it blocks the sperm from getting into the womb. (
  • Barrier devices prevent the sperm from meeting the egg. (
  • A diaphragm is a device similar to the cervical cap, though made of flexible rubber. (
  • As with the diaphragm and the cervical cap, this birth control device has the risk of toxic shock syndrome when not removed after several hours. (
  • N = 734) intrauterine device were compared to women who received a vaginal ring that released about 10 mg daily of progesterone (N = 802) beginning at day 29 to 63 postpartum. (
  • Emergency contraceptives (e.g. (
  • 3 ] The copper IUD is considered to be the most effective emergency contraceptive when inserted up to 5 days after unprotected intercourse. (
  • The Essure Contraceptive Device is a medical device touted as the only nonsurgical sterilization device. (
  • Over 5,000 formal complaints have been filed with the FDA regarding women who experienced harmful complications from the Essure device. (
  • There have been nine total deaths related to the device, four adults and five unborn fetus', all of which involved a pregnancy that the Essure device was intended to prevent. (
  • Congressman Mike Fitzpatrick (R-PA) is introducing a bill to ban the Essure device from the market. (
  • He cites over 22,000 women who have come forward on Facebook alone to report harmful complications and side effects resulting from the Essure Sterilization device. (
  • Such is the case with the Essure device, as many of the women who suffer serious injury with the implanted device end up requiring a complete hysterectomy to reverse the injuries suffered. (
  • Our law firm believes you should be compensated for injuries sustained by a dangerous or defective medical product , like the Essure contraceptive device. (
  • If you have been implanted with an Essure device, you may be eligible for compensation for any injuries or complications sustained as a result of that device. (
  • June 6, 2016 ( LifeSiteNews ) - The U.S. Food and Drug Administration has used faulty data to approve many high-risk ob-gyn medical devices in the last 15 years, a new study says, including the controversial contraceptive device Essure. (
  • Recent controversies surrounding obstetrics and gynecology devices" including among other things, the Essure contraceptive coil device, "highlight the need for deeper understanding of obstetrics and gynecology medical device regulation," the study's authors, based at Northwestern University, said . (
  • The authors identified Essure, classified as a "permanent contraceptive device" intended to last a lifetime, as among 18 devices posing the greatest risk to patients that were green-lighted by the FDA between 2000 and 2015. (
  • According to the BBC, the woman agreed to having a contraceptive injection every three months, but did not want to be fitted with a contraceptive device. (
  • If you are extra cautious, taking an oral contraceptive pill daily should be included in your routine. (
  • An open-label, two-center, randomized study in breastfeeding women compared a copper-containing IUD (Multiload Cu250) with an oral progestin-only contraceptive (lynestrenol 500 mcg). (
  • Israel's Globes newspaper is reporting that Ocon Medical is about to begin clinical trials of company's IUB (Intra Uterine Ball) contraceptive device that was designed to solve a few of the possible implantation downsides of current offerings, such as malpositioning, perforations, and expulsions. (
  • When deployed into the uterine cavity, the IUB™ turns away from the fundus, maintains a diameter larger than the cervical canal and has superior flexibility and minimal tissue protrusion compared to current devices. (
  • Effect of an intrauterine contraceptive device on uterine motility in the rat. (
  • 2. Intrauterine device use among women with uterine fibroids: a systematic review. (
  • 15. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study. (
  • Birth control is the use of various devices, drugs, agents, sexual practices, or surgical procedures to prevent conception or pregnancy. (
  • The study's are asking why the FDA has lowered standards for high-risk medical devices than many drugs. (
  • Xu further questioned the fact that medical devices have lower approval criteria than drugs. (
  • The important question to ask is: should we really be holding high-risk medical devices to a lower standard of evidence than drugs? (
  • A range of devices and treatments are available for both men and women that can help prevent pregnancy. (
  • Access to comprehensive contraceptive counseling is critical to address the timing and choice regarding family planning and prevention of pregnancy. (
  • Some women also report of getting urinary tract infection because of this device. (
  • Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. (
  • Immediate postpartum intrauterine contraceptive device utilization and associated factors among women who gave birth in public health facilities of Adama town, Ethiopia. (
  • Devices are a huge part of the medical care that we provide women on a daily basis," the study's lead author Doctor Jessica Walter said. (
  • 1. Intrauterine device use among women with ovarian cancer: a systematic review. (
  • 8. Use of intrauterine devices in nulliparous women. (
  • 10. [Reasons for removal of intrauterine devices among women in general practice]. (
  • Copper IUD, which is a small, T-shaped device that a provider inserts into the within 120 hours of unprotected intercourse. (
  • For the sake of discussion, some contraceptives are classified under the barrier birth control method. (
  • However, it might take a little while to get used to and some men might get turned off by this barrier birth control device. (
  • Our results reveal significant weaknesses in the preapproval and post approval regulation of high-risk obstetrics and gynecology devices. (
  • The Northwestern University study's authors say that their results, published in the June 2016 journal Obstetrics and Gynecology , show that the FDA approvals should be based upon more rigorous clinical studies than required now, both before and after the devices make it onto the market. (
  • Our concern is that this would lead to more devices getting approved with even less clinical evidence that they are both safe and effective. (
  • This t-shape device is typically made of plastic and copper. (
  • Two groups used copper-containing intrauterine devices (Copper 380A [n = 33] and Copper 200B [n = 29]), and a third group that did not use any IUD (n = 33) served as control. (
  • Four of the devices, or 22 percent, were approved despite failing to demonstrate effectiveness in clinical trials. (
  • Unfortunately, this most recent study is not unique: many studies have shown that the FDA frequently approves even the highest-risk medical devices without adequate evidence of safety and effectiveness," said Sarah Sorscher, researcher with Public Citizen , a watchdog organization founded by consumer advocate Ralph Nader. (
  • The Family Planning Association approved list of contraceptives : based on available data on efficacy and acceptability. (
  • These inserted devices also need to be reapplied before each and every sexual act in order to achieve efficacy in birth control. (
  • Insist on the use of birth control devices as a sign of maturity and deference to the overall health of both partners. (
  • Traditional birth control does not involve any type of device or medication. (
  • Depending on which type of IUD you choose, the device can last between three and ten years, with an efficacy rate of up to 99.8 percent. (
  • 1 = A condition for which there is no restriction for the use of the contraceptive method. (
  • 4 = A condition that represents an unacceptable health risk if the contraceptive method is used. (
  • Ironically, surgery is often required to correct the damage done by a medical device intended to avoid surgery. (
  • Sometimes, even that is not enough, sometimes, the injuries sustained from this defective medical device are permanent. (
  • 3) Except as authorized by regulation, no person shall advertise to the general public any contraceptive device or any drug manufactured, sold or represented for use in the prevention of conception. (
  • Authors of the study also expressed concern over the "21st Century Cures Act," legislation passed last year in the U.S. House of Representatives containing provisions to reduce medical device regulation that is now under consideration in the Senate. (
  • The program addresses development of both male and female contraceptives. (
  • Is there a copayment waiver for contraceptive services? (
  • This comprehensive communication campaign focuses on raising awareness of contraceptive options as well as drawing attention to recent copayment waivers. (
  • Researchers have been trying to develop another contraceptive option for men. (
  • As a Louisiana injury law firm that handles defective medical device claims and pharmaceutical litigation , we meet far too many people who were injured by a medical device that was marketed deceptively - you deserve to know the risks involved before you agree to a device. (
  • In addition to supporting contraceptive development research on validated modulations, this FOA supports early stage, high-risk projects lacking validation by allowing validation during the R61 phase. (
  • This device must not remain in the body for more than 48 hours, to avoid toxic shock syndrome, and would need to be replaced yearly. (
  • We found that there's an opportunity to increase the burden of proof required for a device to be approved for public use. (
  • Strategies to raise pregnant mothers ' awareness of IPPIUCD through mass media , and integrating standard counseling on immediate postpartum intrauterine device (IPPIUD) during antenatal care , and the immediate postpartum period are required to improve IPPIUD utilization. (